980
Participants
Start Date
January 31, 2010
Primary Completion Date
September 30, 2010
Study Completion Date
September 30, 2010
Telmisartan (Kinzal/Pritor, BAY68-9291)
Patients treated with telmisartan tablets under the real-life setting. Dosing regimen customised to the needs of each participating patient according to the investigators assessment
Many Locations
Lead Sponsor
Bayer
INDUSTRY